Literature DB >> 17596251

Short communication: post-kala-azar dermal leishmaniasis--an appraisal.

V Ramesh1, Ruchi Singh, Poonam Salotra.   

Abstract

This short descriptive paper assesses diagnostics, clinical characteristics and therapy of both Indian and African post-kala-azar dermal leishmaniasis.

Entities:  

Mesh：

Year:  2007        PMID： 17596251     DOI： 10.1111/j.1365-3156.2007.01854.x

Source DB:  PubMed          Journal:  Trop Med Int Health        ISSN： 1360-2276            Impact factor:   2.622


  14 in total

1.  Post Kala Azar dermal leishmaniasis in a 15-month-old Greek boy.

Authors:  D Doganis; M Mavrikou; M Tsolia
Journal:  Hippokratia       Date:  2015 Jan-Mar       Impact factor: 0.471

2.  Serological and Molecular Analysis of Leishmania Infection in Healthy Individuals from Two Districts of West Bengal, India, Endemic for Visceral Leishmaniasis.

Authors:  Himanshu Kaushal; Sujit Kumar Bhattacharya; Sandeep Verma; Poonam Salotra
Journal:  Am J Trop Med Hyg       Date:  2017-06       Impact factor: 2.345

3.  Indian erythrodermic postkala-azar dermal leishmaniasis.

Authors:  Gomathy Sethuraman; Neetu Bhari; Poonam Salotra; Venkatesh Ramesh
Journal:  BMJ Case Rep       Date:  2017-01-27

4.  Atypical lesions as a sign of cutaneous dissemination of visceral leishmaniasis in a human immunodeficiency virus-positive patient simultaneously infected by two viscerotropic Leishmania species.

Authors:  Joanna R Santos-Oliveira; Alda M Da-Cruz; Lucy H S Pires; Elisa Cupolillo; Katrin Kuhls; Carmem B W Giacoia-Gripp; Manoel P Oliveira-Neto
Journal:  Am J Trop Med Hyg       Date:  2011-07       Impact factor: 2.345

5.  [Generalized old world leishmaniasis: first Moroccan case in an immunocompetent adult?]

Authors:  Soumiya Chiheb; Zineb Tazi Saoud; Imane El Idrissi Saik; Dounia Darif; Fouzia Hali; Fatima Zahra El Fatoiki; Hayat Skali Dahbi; Ayyoub Kihel; Ikram Hammi; Maha Soussi Abdellaoui; Myriam Riyad
Journal:  Med Trop Sante Int       Date:  2021-11-05

6.  Quantification of parasite load in clinical samples of leishmaniasis patients: IL-10 level correlates with parasite load in visceral leishmaniasis.

Authors:  Sandeep Verma; Rajesh Kumar; Gajendra Kumar Katara; Laishram Chandreshwor Singh; Narender Singh Negi; V Ramesh; Poonam Salotra
Journal:  PLoS One       Date:  2010-04-09       Impact factor: 3.240

7.  Evaluation of cellular immunological responses in mono- and polymorphic clinical forms of post-kala-azar dermal leishmaniasis in India.

Authors:  H Kaushal; R Bras-Gonçalves; K Avishek; D Kumar Deep; E Petitdidier; J-L Lemesre; G Papierok; S Kumar; V Ramesh; P Salotra
Journal:  Clin Exp Immunol       Date:  2016-05-04       Impact factor: 4.330

8.  Post Kala-Azar dermal leishmaniasis following treatment with 20 mg/kg liposomal amphotericin B (Ambisome) for primary visceral leishmaniasis in Bihar, India.

Authors:  Sakib Burza; Prabhat Kumar Sinha; Raman Mahajan; Marta González Sanz; María Angeles Lima; Gaurab Mitra; Neena Verma; Pradeep Das
Journal:  PLoS Negl Trop Dis       Date:  2014-01-02

Review 9.  Immune regulation during chronic visceral leishmaniasis.

Authors:  Rebecca J Faleiro; Rajiv Kumar; Louise M Hafner; Christian R Engwerda
Journal:  PLoS Negl Trop Dis       Date:  2014-07-10

10.  Role of CD8(+) T cells in protection against Leishmania donovani infection in healed Visceral Leishmaniasis individuals.

Authors:  Himanshu Kaushal; Rachel Bras-Gonçalves; Narender Singh Negi; Jean-Loup Lemesre; Gérard Papierok; Poonam Salotra
Journal:  BMC Infect Dis       Date:  2014-12-03       Impact factor: 3.090
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.